UP

Brazilian company to produce Russian vaccine

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

The Brazilian pharmaceutical company Unión Química will produce a Covid-19 Russian vaccine of which it is expected today to manufacture up to eight million doses per month.

Axar.az reports citing foreign media that company´s authorities confirmed.

The G1 news portal assured that such revalidation was issued to a foreign news agency by the company's International Business Director Rogerio Rosso.

Such a phase is a trial used in humans. Although it is included in the request, ANVISA did not reveal the number of volunteers or the places where the research must be carried out in the country, if it is approved.

The vaccine developed by the Gamaleya Research Institute, is the same immunizer that was applied in Argentina and Belarus, and the first one to be worldwide registered to fight Covid-19 in August.

Russia recently published some data with the final result of the vaccine's effectiveness, with 91%.

Date
2021.01.09 / 19:56
Author
Axar.az
See also

Millions at risk as US ends AIDS funding - UNAIDS report

Smart hydrogel developed to heal chronic wounds faster

WHO pushes bold reforms, launching 3 by 35 initiative

Scientists discover new coronavirus

Azerbaijan performs first deceased donor organ transplants

Fifty countries affected by USAID freeze - WHO

Monkeypox case confirmed in Azerbaijan

WHO calls for international support to fund aid in Gaza

30 metapneumovirus cases reported in Kazakhstan

Human metapneumovirus epidemic reported in China

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla